James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is unchanged from the number of companies cited in the previous year.
The citations in the county include:
- Procedures for management review have not been adequately established.
- Procedures for quality audits have not been adequately established.
- Validation of device software is inadequate.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
IncludeHealth | Devices | 11/01/2023 | Management review - Lack of or inadequate procedures |
IncludeHealth | Devices | 11/01/2023 | Quality audits - Lack of or inadequate procedures |
IncludeHealth | Devices | 11/01/2023 | Design validation - software validation not performed |
IncludeHealth | Devices | 11/01/2023 | Lack of or inadequate procedures |
IncludeHealth | Devices | 11/01/2023 | Lack of or inadequate complaint procedures |